|
How to Establish MDD for Creams and Ophthalmic Solutions
|
|
1
|
99
|
December 22, 2025
|
|
N-nitroso-rivaroxaban amide
|
|
6
|
1733
|
December 17, 2025
|
|
Nitrosamines in macrocyclic antibiotics
|
|
2
|
187
|
December 10, 2025
|
|
Levetiracetam_Presence of Nitrosamines
|
|
0
|
106
|
December 9, 2025
|
|
FDA Approves Reformulated Ranitidine - Nitrosamine Impurities - NDMA
|
|
3
|
359
|
November 27, 2025
|
|
Peptide Synthesis - Does anyone have experience with potential Nitrosamine impurities coming from solid phase synthesis?
|
|
1
|
181
|
October 16, 2025
|
|
👨💻 Quantitative Analysis of N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), and -Nitroso-N-methyl-4-aminobutyric acid (NMBA) in Losartan Potassium Tablets by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
|
|
1
|
277
|
September 24, 2025
|
|
Nitrosamine CPCA
|
|
5
|
338
|
September 18, 2025
|
|
👨💻 Quantitative Analysis of NDMA, N-Nitroso-l-ephedrine and N-Nitroso-pseudoephedrine in Pseudoephedrine Hydrochloride by HPLC-Tandem MS
|
|
2
|
448
|
August 28, 2025
|
|
Low recovery factor & Validation Issue
|
|
11
|
549
|
July 22, 2025
|
|
MEGLUMINE (Methylglucamine)
|
|
27
|
3299
|
July 10, 2025
|
|
CMO Nitrosamine Risk Assessment
|
|
7
|
454
|
June 27, 2025
|
|
Nitrosamines in Carbamazepine?
|
|
5
|
924
|
June 27, 2025
|
|
👨💻 Quantitative Analysis of N-Nitrosodimethylamine in Metformin HCl by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
|
|
4
|
574
|
June 3, 2025
|
|
Separation of Nitrosamines and Ranitidine
|
|
3
|
216
|
May 27, 2025
|
|
N-nitroso Torasemide Impurity formation and control
|
|
33
|
2418
|
May 27, 2025
|
|
Cleaning procedure for glassware used in the analysis of nitrosamines for LC-MS/MS
|
|
2
|
381
|
May 23, 2025
|
|
N-Nitrosamine impurity of heterocyclic aromatic ring
|
|
17
|
3955
|
May 13, 2025
|
|
Total Nitrosamine Analyzer
|
|
3
|
283
|
May 12, 2025
|
|
Health Canada: Nitrosamine impurities Update July 26, 2024
|
|
16
|
1728
|
May 9, 2025
|
|
MDD for Metformin
|
|
4
|
289
|
May 2, 2025
|
|
🇰🇷 Korea NRA on 'Case Studies on Reducing Impurities in Pharmaceuticals (focusing on NDMA)"
|
|
0
|
328
|
May 1, 2025
|
|
Autonomous CPCA Web-based calculator FREE
|
|
33
|
6577
|
April 30, 2025
|
|
N-nitrosoamides - a horse of a different color
|
|
54
|
7151
|
March 6, 2025
|
|
To which nitrosamines does the CPCA apply?
|
|
2
|
558
|
February 6, 2025
|
|
What is CPCA Score for “N-nitroso of 3-Amino-1,2,4-triazole"
|
|
7
|
535
|
January 30, 2025
|
|
Acceptable Intake N-Nitrosobiotin (N-Nitrosamide)
|
|
2
|
303
|
January 13, 2025
|
|
Development of a Simultaneous Analytical Method for Amines Corresponding to 10 Typical Nitrosamines
|
|
0
|
632
|
December 30, 2024
|
|
Formation of Nitroso-Omeprazole
|
|
5
|
2025
|
December 12, 2024
|
|
Hexamethyldisilazane (HMDS) can form Nitrosamine Impurity?
|
|
7
|
588
|
October 29, 2024
|